Home  |  Contact

Cellosaurus P3X63Ag8U.1 (CVCL_3412)

[Text version]

Cell line name P3X63Ag8U.1
Synonyms P3-X63-Ag8-U1; P3-X63-Ag8.U1; P3-X63.Ag8.U1; P3X63-Ag8-U1; P3X63Ag8-U1; P3X63Ag8.U1; P3.x63.Ag8.U1; P3U1; P3UI; P3U-1; P3-U1
Accession CVCL_3412
Secondary accession CVCL_4268
Resource Identification Initiative To cite this cell line use: P3X63Ag8U.1 (RRID:CVCL_3412)
Comments Group: Hybridoma fusion partner cell line.
Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
Disease Mouse plasma cell myeloma (NCIt: C125417)
Species of origin Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Breed/subspecies: BALB/c.
Hierarchy Parent: CVCL_3411 (P3X63Ag8)
Children:
CVCL_H997 (10C4.1.3)CVCL_H998 (10H2.12.1)CVCL_J064 (15-1-5P)
CVCL_IQ41 (15B3)CVCL_A6KQ (182-D1106-055)CVCL_A6KR (182-D1106-056)
CVCL_A6KS (182-D1106-057)CVCL_A6KT (182-D1106-058)CVCL_A6KU (182-D1106-059)
CVCL_A6LA (182-D1106-061)CVCL_A6KV (182-D1106-062)CVCL_A6KW (182-D1106-067)
CVCL_A6LB (182-D1106-279)CVCL_A6LC (182-D1106-294)CVCL_A6LD (182-D1106-362)
CVCL_A6KX (182-D758-035)CVCL_A6KY (182-D758-036)CVCL_A6KZ (182-D758-040)
CVCL_H999 (1A3.3.13)CVCL_A7DJ (1E7 [Mouse hybridoma against mouse Celf3])CVCL_J986 (1G10.1.5)
CVCL_B0JZ (1G3 [Mouse hybridoma against human FOLH1])CVCL_B0K0 (1G9)CVCL_B0EB (1H5.25.9)
CVCL_9148 (2.4G2)CVCL_A7VJ (2A10)CVCL_B0K1 (2C7 [Mouse hybridoma against human FOLH1])
CVCL_A7VR (2F2 [Mouse hybridoma against P.vivax circumsporozoite protein])CVCL_J704 (2F8 [Mouse hybridoma against human OXTR])CVCL_A0QQ (30G8)
CVCL_9159 (33D1)CVCL_IQ40 (34C9)CVCL_A0QR (34H1)
CVCL_A0QS (35A6)CVCL_A0QT (35H5)CVCL_A0QU (38B7)
CVCL_A0QV (39E8)CVCL_J721 (3A21)CVCL_J000 (3C10 [Mouse hybridoma against human CD14])
CVCL_B0K2 (3C2 [Mouse hybridoma against human FOLH1])CVCL_B0K3 (3C4 [Mouse hybridoma against human FOLH1])CVCL_B0K4 (3C6 [Mouse hybridoma against human FOLH1])
CVCL_B0K5 (3C9)CVCL_A7VE (3D11)CVCL_B0EM (3D5.1.10)
CVCL_B0K6 (3D7-1.1)CVCL_B0K7 (3E11)CVCL_B0K8 (3E6 [Mouse hybridoma against human FOLH1])
CVCL_DN55 (3F5.4G6)CVCL_B0K9 (3G6 [Mouse hybridoma against human FOLH1])CVCL_B0EK (3H1.18.10)
CVCL_B0EL (3H3.14.5)CVCL_J048 (4B2 [Mouse hybridoma against human PTPRC])CVCL_J987 (4C7.2.1)
CVCL_B0KA (4C8B9)CVCL_J001 (4D1.5.7)CVCL_B0KB (4D4 [Mouse hybridoma against human FOLH1])
CVCL_B0KC (4D8)CVCL_A9PB (4E1-7)CVCL_B0KD (4E10-1.14)
CVCL_B0EC (4E7.24.3)CVCL_C560 (4G12 [Mouse hybridoma against human 65 kDa glycoprotein])CVCL_B0ED (4G7.18.8)
CVCL_B0EE (4H6.17.8)CVCL_J988 (5B6.3.10)CVCL_J002 (5D5.11.6)
CVCL_B0EF (5G11.17.1)CVCL_XK20 (5G7)CVCL_WZ40 (6B3 [Mouse hybridoma against human LGALS3BP])
CVCL_J989 (6D11.3.1)CVCL_J003 (6G4.2.5)CVCL_IQ39 (6H4)
CVCL_XX88 (6H7)CVCL_J049 (71A7)CVCL_J990 (7B6.15.11)
CVCL_J739 (9.3F10)CVCL_M908 (9D4.9.1)CVCL_M909 (9G2.1.3)
CVCL_J004 (A5.12.14)CVCL_2573 (AF-2 clone 9B5)CVCL_A7DK (Anti-6330403k07Rik)
CVCL_U830 (anti-alphaA-crystallin)CVCL_U813 (anti-alphaB-crystallin)CVCL_U826 (anti-beta5-crystallin)
CVCL_U827 (anti-beta6-crystallin)CVCL_WI43 (anti-beta8-crystallin)CVCL_U829 (anti-delta-crystallin)
CVCL_A7DL (Anti-Dgcr14)CVCL_U828 (anti-gamma1-crystallin)CVCL_A6KA (APM-1)
CVCL_A6KB (APM-2)CVCL_A6KC (APM-3)CVCL_XE24 (Ax223)
CVCL_XE25 (Ax225)CVCL_XE26 (Ax232)CVCL_XE27 (Ax258)
CVCL_XE28 (Ax284)CVCL_XE29 (Ax285)CVCL_XE30 (Ax292)
CVCL_XE31 (Ax51)CVCL_XE32 (Ax7)CVCL_XE33 (Ax96)
CVCL_9164 (B21-2)CVCL_U122 (BBWV-22K3-9B)CVCL_U123 (BBWV-22K5-12A)
CVCL_U124 (BBWV-22K6-2A)CVCL_A8V2 (C20Mab-11)CVCL_A8V3 (C20Mab-60)
CVCL_U814 (D134)CVCL_U815 (D16 [Mouse hybridoma against H.crassispina dynein IC3])CVCL_U816 (D264)
CVCL_U817 (D308)CVCL_U818 (D52)CVCL_U819 (D58)
CVCL_J011 (D8/17)CVCL_U820 (D9)CVCL_U663 (DA-3 [Mouse hybridoma against domoic acid])
CVCL_A1KJ (Ep-C4)CVCL_A9J9 (F3-B2)CVCL_XA78 (FIB1-11)
CVCL_XA79 (FIB2-11)CVCL_A5WZ (FU-MK-1)CVCL_T774 (G1MF285D)
CVCL_XQ70 (GAL-FR21)CVCL_XS99 (GAL-FR22)CVCL_XT67 (GAL-FR23)
CVCL_6F34 (gamma2-11.1)CVCL_2770 (gamma3-11.1)CVCL_U125 (GT-13A)
CVCL_A6WY (HECD-1)CVCL_U188 (HH13-1)CVCL_U189 (HH17-4)
CVCL_9V73 (HM-5 [Human/mouse heteromyeloma])CVCL_KR85 (HS-7)CVCL_0339 (IB4)
CVCL_A1LP (ITK-2)CVCL_A1LQ (ITK-3)CVCL_B0PV (KM-10)
CVCL_J012 (L11/135)CVCL_XC23 (LCDV-E1)CVCL_XC24 (LCDV-E2)
CVCL_XC25 (LCDV-V)CVCL_G208 (LK-4)CVCL_KA00 (M2590)
CVCL_KA01 (M562)CVCL_KA02 (M622)CVCL_KB25 (MBr1)
CVCL_7201 (MH60.BSF2)CVCL_CW88 (MIH5)CVCL_CW89 (MIH6)
CVCL_U130 (MVP1)CVCL_U131 (MVP25)CVCL_U132 (MVP47)
CVCL_U133 (MVP49)CVCL_U134 (MVP51)CVCL_A6WZ (NCC-CAD-299)
CVCL_A6XA (NCD-2)CVCL_YA16 (NZ-1.2)CVCL_G132 (OKM1)
CVCL_2662 (OKT 1)CVCL_2663 (OKT 10)CVCL_2664 (OKT 11)
CVCL_2665 (OKT 3)CVCL_2666 (OKT 4)CVCL_2667 (OKT 5)
CVCL_2668 (OKT 6)CVCL_2669 (OKT 8)CVCL_2670 (OKT 9)
CVCL_L098 (OM1)CVCL_L099 (OM2)CVCL_L097 (OM3)
CVCL_L100 (OM4)CVCL_A6XB (PCD-1)CVCL_XC30 (PE 9)
CVCL_XC31 (PG 11)CVCL_YA15 (PMab-1)CVCL_UG46 (PMab-202)
CVCL_YA06 (PMab-219)CVCL_DN67 (PSM-P12)CVCL_9233 (R4-6A2)
CVCL_YQ11 (rSN-122)CVCL_YQ12 (rSN-150)CVCL_YQ10 (rSN-18)
CVCL_YQ13 (rSN-21-2)CVCL_YQ14 (rSN-29)CVCL_LK87 (T1-18)
CVCL_A6ZU (T49-25)CVCL_UD60 (TCC56)CVCL_A7BN (TFL-21-7G)
CVCL_JX83 (TFS-1)CVCL_J858 (TFS-2)CVCL_JX84 (TFS-3)
CVCL_J859 (TFS-4)CVCL_F246 (TM 902)CVCL_F247 (TM 903)
CVCL_XA80 (TPA1-148)CVCL_XA81 (TPA1-39)CVCL_XA82 (TPA1-41)
CVCL_XA83 (TPA1-70)CVCL_XA84 (TPA2-135)CVCL_XA85 (TPA2-14)
CVCL_XA86 (TPA2-6)CVCL_B0XH (Trk27)CVCL_B0XI (Trk49)
CVCL_B0XJ (Trk62)CVCL_B0XK (Trk73)CVCL_K256 (TX-7F)
CVCL_CW90 (TY25)CVCL_XA87 (UK1-3)CVCL_XA88 (UK1-6)
CVCL_XA89 (UK1-87)CVCL_U860 (UV-P3U1-B8)CVCL_XB56 (WSSV-3B7)
CVCL_XY55 (WSSV-R)CVCL_E987 (YI 328-18)CVCL_E988 (YI 328-51)
Sex of cell Female
Category Cancer cell line
Cross-references
Cell line collections ATCC; CRL-1597
ECACC; 85011417
ECACC; 94120802
ICLC; ATL96012
JCRB; JCRB0708
JCRB; JCRB9085
NCBI_Iran; C579
Cell line databases/resources CLDB; cl3839
CLDB; cl3847
CLDB; cl3848
CLDB; cl3849
CLDB; cl3850
Ontologies CLO; CLO_0008333
CLO; CLO_0008336
Other Wikidata; Q54937289
Entry history
Entry creation04-Apr-2012
Last entry update23-Sep-2021
Version number14